Skip to content
Home/Companies/MedTech/STAT-Diagnostica

STAT-Diagnostica

MedTech·ES·Exited 2018·Held 7yr
Entry
2011
Hold
7yr
Exit
2018

Who owns STAT-Diagnostica?

STAT-Diagnostica was owned by Ysios Capital Partners through Ysios BioFund I (2008 vintage) from 2011 to 2018, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-03

Ysios Capital Partners
Investor
Ysios Capital Partners
Ysios BioFund I · 2008 · Life Sciences VC

Key facts

HQES
SectorMedTech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2018

More from Ysios BioFund I

Other portfolio companies in the same fund.

Galecto Biotech
Exited 2020
BiotechDK· 2018
Sanifit
Exited 2021
BiotechES· 2015
to
KALA BIO
Kala BIO
Exited 2017
BiotechUS· 2014
AM Pharma
AM Pharma
Active
BiotechNL· 2011
MedLumics
Active
MedTechES· 2011
BioVex
Exited 2011
BiotechUS· 2009
to

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Optos
Exited 2015
Amadeus Capital PartnersUK
to
Axomove
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Clee Medical
Clee Medical
Active
High-Tech Gruenderfonds (HTGF)Switzerland· 2026
CollimateHealth
Active
Caesar Ventures ManagementGermany· 2026
Track STAT-Diagnostica

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on STAT-Diagnostica.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue